August 4, 2008 - EKR Therapeutics Inc., said today it received FDA approval for Cardene I.V. (nicardipine hydrochloride) premixed injection, a patented, ready-to-use, single use intravenous bag for the administration of this calcium channel blocker. The 200 ml RTU bags contain 20 mg of the anti-hypertensive agent nicardipine hydrochloride (0.1 mg/ml) in either dextrose or sodium chloride.

August 1, 2008 - Healthcare professionals need an authoritative resource on the Internet designed to quickly provide ...

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k) clearance last week from the FDA the company has commenced shipments of its second generation eSensor XT-8 molecular diagnostics platform and Warfarin Sensitivity Test.

July 31, 2008 – A survey of cardiovascular catheterization laboratories in the U.S. found obese patients who weigh more ...

July 31, 2008 – No major difference was found in long-term safety or efficacy between sirolimus-eluting stents (SES) and ...

July 30, 2008 - Having completed clinical trials of its ThromboGuide (T-Guide) Platelet aggregation system ...

July 30, 2008 - Researchers at the Ohio State University Medical Center have designed equipment to provide high ...